Tiada risiko yang diketahui terhadap kecacatan janin selepas penggunaan mifepristone.
Penggunaan misoprostol dalam 12 minggu pertama kehamilan dikaitkan dengan sedikit peningkatan risiko kecacatan janin. Risikonya sangat rendah, iaitu kurang daripada 10 dalam 1,000 kehamilan yang berterusan. Kebanyakan kecacatan ini tidak dapat dikesan melalui imbasan ultrasound.
Selepas 12 minggu, tiada peningkatan risiko sama sekali.
Sumber
- Turner, Joseph V., Deborah Garratt, Anna Barwick, Lucas A. McLindon, M. Joy Spark, and Angela Smith. 2024. ‘Congenital and Fetal Effects After Mifepristone Exposure and Continuation of Pregnancy: A Systematic Review’. Clinical Pharmacology and Therapeutics, November. https://doi.org/10.1002/cpt.3392
- Philip, Neena, Caitlin S Shannon, and Beverly Winikoff. 2003. ‘Misoprostol and Teratogenicity: Reviewing the Evidence. Report of a Meeting.’ Robert H. Ebert Program on Critical Issues in Reproductive Health Publication Series. New York: Population Council and Gynuity Health Products. https://knowledgecommons.popcouncil.org/cgi/viewcontent.cgi?article=2658&context=departments_sbsr-rh
